InvestorsHub Logo
Post# of 4979580
Next 10
Followers 82
Posts 2822
Boards Moderated 0
Alias Born 05/05/2006

Re: None

Wednesday, 05/25/2011 2:56:50 PM

Wednesday, May 25, 2011 2:56:50 PM

Post# of 4979580
RXII $.98 ASCO Blockbuster results

RXII could be $3 in no time like ZLCS and ACAD. RXII has a blockbuster cancer vaccine with unprecedented results approved for an SPA.

The vaccine reduced breast cancer recurrance from 14% to 2%. ober a 2 year period.

That trumps DNDN.

Updated results at ASCO.

Only 30 MM float and $20 MM cash. Market valuing thus vaccine at basically 0.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.